SUTRO BIOPHARMA, INC. (STRO)

SEC filing

SUTRO BIOPHARMA, INC.

STRO · CIK 1382101

4 · Sep 22, 2026 · CHIEF SCIENTIFIC OFFICER Gerber Hans-Peter exercised options for 7,500 shares; reported 1,345 shares

CHIEF SCIENTIFIC OFFICER Gerber Hans-Peter exercised options for 7,500 shares; reported 1,345 shares

Could not load the primary document from EDGAR (SEC rate limit, timeout, or temporary upstream error). Refresh in a minute, or use View on SEC.gov.